Facile route to versatile nanoplatforms for drug delivery by one-pot self-assembly

Acta Biomaterialia

Volumn 10, Issue 6, 2014, Pages 2630-2642

  Zhou, Xing ^a   Che, Ling ^b   Wei, Yanling ^c   Dou, Yin ^a   Chen, Sha ^a   He, Hongmei ^a   Gong, Hao ^a   Li, Xiaohui ^a   Zhang, Jianxiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Drug delivery; Gene therapy; Nanomedicine; Nanoparticle; Self assembly

Indexed keywords

BIOCHEMISTRY; CONTROLLED DRUG DELIVERY; COST EFFECTIVENESS; GENE THERAPY; MEDICAL NANOTECHNOLOGY; SELF ASSEMBLY; SURFACE CHEMISTRY; TARGETED DRUG DELIVERY;

BROAD APPLICATION; CARBOXYL GROUPS; COST EFFECTIVE; NANOCONTAINERS; NANOPARTICLE FORMATION; NANOPHARMACEUTICALS; ONE POT; PACLITAXEL; THERAPEUTIC ACTIVITY; WATER SOLUBILITIES;

NANOPARTICLES;

CARRAGEENAN; INDOMETACIN; NANOCARRIER; PACLITAXEL; PLASMID DNA; POLYETHYLENEIMINE NANOPARTICLE; RAPAMYCIN; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA PACKAGING; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; FEMALE; HELA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MCF 7 CELL LINE; MULTIDRUG RESISTANCE; NANOMEDICINE; NONHUMAN; ONE POT SELF ASSEMBLY; ONE POT SYNTHESIS; PRIORITY JOURNAL; RAT; SOLUBILITY; ANIMAL; NANOTECHNOLOGY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; MALE; NANOTECHNOLOGY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899652042     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.01.024     Document Type: Article

References (51)

1. Duncan R. The dawning era of polymeric therapeutics. Nat Rev Drug Discov 2003;2:347-60.
2. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82.
3. Kim BYS, Rutka JT, Chan WCW. Nanomedicine. N Engl J Med 2010;363: 2434-43.
4. Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012;41:2971-3010.
5. Cabral H, Nishiyama N, Kataoka K. Supramolecular nanodevices: from design validation to theranostic nanomedicine. Acc Chem Res 2011;44:999-1008.
6. Cheng ZL, Zaki AA, Hui JZ, Muzykantov VR, Tsourkas A. Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 2012;338:903-10.
7. Tomasina J, Lheureux S, Gauduchon P, Rault S, Malzert-Freon A. Nanocarriers for the targeted treatment of ovarian cancers. Biomaterials 2013;34:1073-101.
8. Kesharwani P, Gajbhiye V, Jain NK. A review of nanocarriers for the delivery of small interfering RNA. Biomaterials 2012;33:7138-50.
9. Yoo JW, Irvine DJ, Discher DE, Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov 2011;10:521-35.
10. Lobatto ME, Fuster V, Fayad ZA, Mulder WJM. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov 2011;10:835-52.
11. Miyata K, Nishiyama N, Kataoka K. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses. Chem Soc Rev 2012;41:2562-74.
12. Abeylath SC, Ganta S, Iyer AK, Amiji M. Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery. Acc Chem Res 2011;44:1009-17.
13. Campolongo MJ, Tan SJ, Xu JF, Luo D. DNA nanomedicine: engineering DNA as a polymer for therapeutic and diagnostic applications. Adv Drug Deliv Rev 2010;62:606-16.
14. Patel T, Zhou JB, Piepmeier JM, Saltzman WM. Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 2012;64:701-5.
15. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009;3:16-20.
16. Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 2009;48:5418-29.
17. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010;9:615-27.
18. Zhang JX, Ma PX. Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications. Nano Today 2010;5:337-50.
19. Tyrrell ZL, Shen YQ, Radosz M. Fabrication of micellar nanoparticles for drug delivery through the self-assembly of block copolymers. Prog Polym Sci 2010;35:1128-43.
20. Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm 2011;8:2101-41.
21. Zhang JX, Li XD, Li XH. Stimuli-triggered structural engineering of synthetic and biological polymeric assemblies. Prog Polym Sci 2012;37:1130-76.
22. van de Manakker F, Vermonden T, van Nostrum CF, Hennink WE. Cyclodextrinbased polymeric materials: synthesis, properties, and pharmaceutical/ biomedical applications. Biomacromolecules 2009;10:3157-75.
23. Davis ME. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 2009;6:659-68.
24. Venditto VJ, Szoka FC. Cancer nanomedicines: so many papers and so few drugs. Adv Drug Deliv Rev 2013;65:80-8.
25. Shi JJ, Xiao ZY, Kamaly N, Farokhzad OC. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res 2011;44:1123-34.
26. Shen YQ, Jin EL, Zhang B, Murphy CJ, Sui MH, Zhao J, et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc 2010;132:4259-65.
27. Yang C, Tan JPK, Cheng W, Attia ABE, Ting CTY, Nelson A, et al. Supramolecular nanostructures designed for high cargo loading capacity and kinetic stability. Nano Today 2010;5:515-23.
28. Zhu YX, Che L, He HM, Jia Y, Zhang JX, Li XH. Highly efficient nanomedicines assembled via polymer-drug multiple interactions: tissue-selective delivery carriers. J Control Release 2011;152:317-24.
29. Zhang JX, Sun HL, Ma PX. Host-guest interaction mediated polymeric assemblies: multifunctional nanoparticles for drug and gene delivery. ACS Nano 2010;4:1049-59.
30. Zhang JX, Ma PX. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 2013;65:1215-33.
31. Zhang JX, Ma PX. Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery. Angew Chem Int Ed 2009;48:964-8.
32. Chen HP, Liu XP, Dou Y, He BF, Liu L, Wei ZH, et al. A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. Biomaterials 2013;34:4159-72.
33. Kircheis R, Wightman L, Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv Drug Deliv Rev 2001;53:341-58.
34. Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 2005;7:992-1009.
35. Lungwitz U, Breunig M, Blunk T, Gopferich A. Polyethylenimine-based nonviral gene delivery systems. Eur J Pharm Biopharm 2005;60:247-66.
36. Wegmann F, Gartlan KH, Harandi AM, Brinckmann SA, Coccia M, Hillson WR, et al. Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens. Nat Biotechnol 2012;30:883-8.
37. Yan Y, Such GK, Johnston APR, Lomas H, Caruso F. Toward therapeutic delivery with layer-by-layer engineered particles. ACS Nano 2011;5:4252-7.
38. De Cock LJ, De Koker S, De Geest BG, Grooten J, Vervaet C, Remon JP, et al. Polymeric multilayer capsules in drug delivery. Angew Chem Int Ed 2010;49:6954-73.
39. Discher DE, Eisenberg A. Polymer vesicles. Science 2002;297:967-73.
40. Zhang JX, Qiu LY, Li XD, Jin Y, Zhu KJ. Versatile preparation of fluorescent particles based on polyphosphazenes: from micro- to nanoscale. Small 2007;3:2081-93.
41. Tang XC, Pikal MJ, Taylor LS. The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers. Pharm Res 2002;4:484-90.
42. Gao WW, Chan JM, Farokhzad OC. pH-responsive nanoparticles for drug delivery. Mol Pharm 2010;7:1913-20.
43. Che L, Zhou JZ, Li SH, He HM, Zhu YX, Zhou X, et al. Assembled nanomedicines as efficient and safe therapeutics for articular inflammation. Int J Pharm 2012;439:307-16.
44. Jia Y, Tang Y, He HM, Li SH, Che L, Zhou X, et al. Nanoassemblies from homostructured polypeptides as efficient nanoplatforms for oral drug delivery. Nanomedicine: NBM 2013;9:408-18.
45. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999;60:149-60.
46. Zhang JX, Li XH, Lou LP, Li XD, Jia Y, Jin Z, et al. Non-viral gene therapy. In: Prokop A, editor. Intracellular delivery: fundamentals and applications. Springer Science+Business Media; 1979. p. 599-699.
47. Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 2006;114:100-9.
48. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003;24:1121-31.
49. Benny O, Fainaru O, Adini A, Cassiola F, Bazinet L, Adini I, et al. An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat Biotechnol 2008;26:799-807.
50. Aouadi M, Tesz GJ, Nicoloro SM, Wang MX, Chouinard M, Soto E, et al. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 2009;458:1180-4.
51. Mei L, Zhang ZP, Zhao LY, Huang LQ, Yang XL, Tang JT, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev 2013;65:880-90.